Table 1.
Entire Cohort (n = 1601) | mRS 0–2 Favorable (n = 1074) | mRS 3–6 Unfavorable (n = 527) | P-value* | |
---|---|---|---|---|
Age (years) (median [IQR], mean ± SD) | 69 [58 – 78], 67.7 ± 13.4 | 67 [57 – 76], 65.6 ± 13.3 | 74 [63 – 82], 72.0 ± 12.7 | < 0.0001 |
Females, n (%) | 788 (49.2%) | 502 (46.7%) | 286 (54.3%) | 0.0048 |
History of hypertension, n (%) | 1264 (79.0%) | 814 (75.8%) | 450 (85.4%) | < 0.0001 |
Diabetes mellitus type 2 | 621 (38.8%) | 375 (34.9%) | 246 (46.7%) | < 0.0001 |
Dyslipidemia | 1148 (71.7%) | 758 (70.6%) | 390 (74.0%) | 0.1569 |
Current or former smoker, n (%) Missing, n | 954 (60.7%) 29 | 648 (61.0%) 11 | 306 (60.1) 18 | 0.7827 |
Alcohol consumption, n (%) Missing, n | 552 (36.5%) 89 | 407 (39.9%) 54 | 145 (29.5%) 35 | < 0.0001 |
BMI ≥ 30, n (%) | 755 (47.2%) | 508 (47.3%) | 247 (46.9%) | 0.8732 |
Peripheral vascular disease, n (%) | 161 (10.1%) | 92 (8.6%) | 69 (13.1%) | 0.0060 |
Coronary artery disease, n (%) | 477 (29.8%) | 286 (26.6%) | 191 (36.2%) | < 0.0001 |
Atrial fibrillation, n (%) | 355 (22.2%) | 197 (18.3%) | 158 (30.0%) | < 0.0001 |
Carotid stenosis, n (%) | 607 (37.9%) | 408 (38.0%) | 199 (37.8%) | 0.9563 |
Intracranial atherosclerotic stenosis, n (%) | 483 (30.2%) | 318 (29.6%) | 165 (31.3%) | 0.4875 |
Anemia, n (%) | 243 (15.2%) | 120 (11.2%) | 123 (23.3%) | < 0.0001 |
Pro-coagulant coagulation disorder, n (%) | 71 (4.4%) | 42 (3.9%) | 29 (5.5%) | 0.1560 |
COPD, n (%) | 188 (11.7%) | 104 (9.7%) | 84 (15.9%) | 0.0004 |
Sleep apnea, n (%) | 170 (10.6%) | 102 (9.5%) | 68 (12.9%) | 0.0468 |
Family history of stroke, n (%) | 358 (22.4%) | 224 (20.9%) | 134 (25.4%) | 0.0412 |
Prior TIA, n (%) | 191 (11.9%) | 120 (11.2%) | 71 (13.5%) | 0.1897 |
Prior stroke (hemorrhagic or ischemic), n (%) | 342 (21.4%) | 200 (18.6%) | 142 (26.9%) | 0.0002 |
P-value: Continuous variables were compared using Wilcoxon rank-sum tests and categorical variables were compared using Fisher’s exact tests.